SBH
AGN

Segall Bryant & Hamill’s Allergan plc AGN Stock Holding History

Segall Bryant & Hamill’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,030
Closed -$340K – 864
2019
Q2 		$340K Sell
2,030
-1,198
-37% -$166K 0.01% 724
2019
Q1 		$472K Sell
3,228
-251
-7% -$36.4K 0.01% 669
2018
Q4 		$465K Sell
3,479
-1,084
-24% -$178K 0.01% 659
2018
Q3 		$869K Sell
4,563
-1,144
-20% -$210K 0.01% 572
2018
Q2 		$951K Sell
5,707
-8,449
-60% -$1.36M 0.01% 548
2018
Q1 		$2.38M Sell
14,156
-13,873
-49% -$2.33M 0.06% 287
2017
Q4 		$4.58M Sell
28,029
-84,017
-75% -$15.1M 0.1% 211
2017
Q3 		$23M Sell
112,046
-14,839
-12% -$3.45M 0.53% 53
2017
Q2 		$30.8M Buy
126,885
+15,372
+14% +$3.61M 0.73% 38
2017
Q1 		$26.6M Buy
111,513
+3,410
+3% +$794K 0.64% 45
2016
Q4 		$22.7M Buy
108,103
+1,799
+2% +$373K 0.57% 61
2016
Q3 		$24.5M Buy
106,304
+24,631
+30% +$6.02M 0.63% 53
2016
Q2 		$18.9M Buy
81,673
+37,330
+84% +$8.61M 0.5% 61
2016
Q1 		$11.9M Buy
44,343
+29,413
+197% +$8.42M 0.29% 98
2015
Q4 		$4.67M Sell
14,930
-322
-2% -$95.9K 0.11% 209
2015
Q3 		$4.15M Buy
15,252
+4,195
+38% +$1.29M 0.1% 232
2015
Q2 		$3.35M Sell
11,057
-402
-4% -$120K 0.08% 267
2015
Q1 		$3.41M Buy
+11,459
New +$3.27M 0.08% 263

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Segall Bryant & Hamill's AGN Position: Q3 2019 in Review

Segall Bryant & Hamill sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 2,030 shares — an estimated $340K sold.

Segall Bryant & Hamill first reported a position in AGN in Q1 2015 and held it in 18 quarters. The position peaked at $30.8M in Q2 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Segall Bryant & Hamill reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Segall Bryant & Hamill sold 2,030 Allergan plc shares in Q3 2019, an estimated $340K.
  • Segall Bryant & Hamill first reported a position in Allergan plc in Q1 2015 and held it in 18 quarters.
  • Segall Bryant & Hamill's Allergan plc position peaked at $30.8M in Q2 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Segall Bryant & Hamill's 13F filing for Q3 2019, filed 12 Nov 2019.